|
References
|
1.
|
Gambhir SS, Czernin J, Schwimmer J, et al. A tabulated summary of the FDG PET literature. J Nucl Med 2001;42(supl): 1S-93S. Volver
|
|
2.
|
Fanti S, Franchi R, Batista G, Monetti N, Canini R. PET and PET-CT. State of the art and future prospects. Radiol Med 2005;110:1-15. Volver
|
|
3.
|
Turkington TG, Bowsher JE. New technologies in nuclear medicine. In: Sandler MP, Coleman RE, Patton JA, Wackers FJTH, Gottschalk A. Diagnostic nuclear medicine. 4th ed. Philadelphia: Lippincott Williams & Wilkins,2003: 85-93. Volver
|
|
4.
|
Costa DC, Visvikis D, Crosdale I, et al. Positron emission and computed X-ray tomography: a coming together. Nuc Med Commun 2003; 24: 351-358. Volver
|
|
5.
|
Czernin J. Schelbert H. PET/CT imaging: facts, opinions, hopes, and questions. J Nucl Med 2004;45(supl):1S. Volver
|
|
6.
|
Patton JA. Basic physics of nuclear medicine. In: Sandler MP, Coleman RE, Patton JA, Wackers FJTH, Gottschalk A. Diagnostic nuclear medicine. 4th ed. Philadelphia: Lippincott Williams & Wilkins,2003: 85-93. Volver
|
|
7.
|
Meikle SR, Dahlbom M. Positron emission tomography. In: Murray IPC, Ell PJ, Van der Wall H, Strauss HW. Nuclear medicine in clinical diagnosis and treatment. 2nd ed. Edinburg: Churchill Livingstone,1998:1603-1616. Volver
|
|
8.
|
Cherry SR, Phelps ME. Positron emission tomography: methods and instrumentation. In: Sandler MP, Coleman RE, Patton JA, Wackers FJTH, Gottschalk A. Diagnostic nuclear medicine. 4th ed. Philadelphia: Lippincott Williams & Wilkins,2003: 61-83. Volver
|
|
9.
|
Beyer T, Townsend DW, Brun T, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000;41:-1369-1379. Volver
|
|
10.
|
Sureshbabu W, Mawlawi O. PET/CT imaging artifacts. J Nucl Med Technol 2005;33:156-161. Volver
|
|
11.
|
Osman MM, Cohade C, Nakamoto Y, wahl RL. Respiratory motion artifacts on PET emission images obtained using CT attenuation correction on PET-CT. Eur J Nucl Med Mol Imaging 2003;30:603-606. Volver
|
|
12.
|
von Schulthess GK, Normal PET and PET/CT body scans: imaging pitfalls and artifacts. In: von-Schulthess GK, ed. Clinical Molecular Anatomic Imaging: PET, PET/CT and SPECT/CT. Baltimore: Lippincott, Williams & Wilkins, 2002:252-270. Volver
|
|
13.
|
Dizendrof EV, treyer V, Von Schuthess GK, et al. Application of oral contrast media in coregistered positron emission tomography-CT. AJR 2002; 179:477-481. Volver
|
|
14.
|
Antoch G, Freudenberg LS, Beyer T, et al. To enhance or not enhance? 18F-FDG and CT cntrast agents in dual-modality 18F-FDG PET/CT. J Nucl Med 2004;45:56S-65S. Volver
|
|
15.
|
Antoch G, Freudenberg LS, Egelhof T, et al. Focal tracer uptake: a potential artifact in contrast-enhanced dual-modality PET/CT scans. J Nucl Med 2002;43:1339-1342. Volver
|
|
16.
|
Cohade C, Osman M, Nakamato Y, et al. Initial experience with oral contrast in PET/CT: phantom and clinical studies. J Nucl Med 2003; 44:412-416. Volver
|
|
17.
|
Dizendorf E, Hany TF, Buck A, von Schulthess GK, Burger C. Cause and magnitude of the error induced by oral CT contrast in CT-based attenuation correction of PET emission studies. J Nucl Med 2003; 44: 732-738. Volver
|
|
18.
|
Schoeder H, Erdi YE, Larso SM, et al. PET/CT: a new imaging technology in nuclear medicine. Eur J Nucl Med Mol Imaging 2003;30:1419-1437.
|
|
19.
|
Bar-shalom R, Yefremov N, Guralnik L, et al. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med 2003;44: 1200-1209. Volver
|
|
20.
|
burger I, Goerres G, von Schulthess GK,et al. PET/CT: diagnostic improvement in recurrent colorectal carcinoma compared to PET alone. Radiology 2002;225:224.
|
|
21
|
. Cohade S, Osman M, Leal J, et al. Direct comparison of 18F-FDG PET and PET/CT in patients with colorectal carcinoma. J Nucl Med 2003;44:1793-1803. Volver
|
|
22.
|
Dehdashti F, Siegel BA. Neoplasm of the esophagus and stomach. Seminars Nucl Med 2004; 34: 198-208. Volver
|
|
23.
|
Abouzied MM, Crawford ES, Nabi HA. 18F-FDG imaging: pitfalls and artifacts. J Nucl Med Technol 2005; 33:145-155. Volver
|
|
24.
|
Goerres GW, Kamel E, Seifert B, et al. Accuracy of image coregistration of pulmonary lesions in patients with non small-cell lung cancer using an integrated PET-CT system. J Nucl Med 2002;43:1469-1475. Volver
|
|
25.
|
Lardinois D, Weder W, Hany TF, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003;348:2500-2507. Volver
|
|
26.
|
Downey RJ, Akhurst T, Ilson D, et al. Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial. J Clin Oncol 2003; 21:428-432. Volver
|
|
27.
|
Kostakoglu L, Goldsmith SJ. PET in the assessment of therapy response in patients with carcinoma of the head and neck and of the esophagus. J Nucl Med 2004; 45: 56-58. Volver
|
|
28.
|
Dizendorf EV, Baumert BG, von Schulthess GK, et al. Impact of whole body 18F-FDG PET on staging and managing for radiation therapy. J Nulc Med 2003; 44: 24-29. Volver
|
|
29.
|
Fanti S, Yu JQ, Morreti A, et al. assessment of disease activity in multiple myeloma with FDG-PET imaging. Eur J Nulc Med Mol Imaging 2004; 31(suppl 2) S 286. Volver
|
|
30.
|
Kostakoglu L, Goldmith SJ. 18F-FDG PET evaluation for lymphoma and for breast, lung and colorectal carcinoma. J Nucl Med 2003;44:224-239. Volver
|
|
|
